[144] C.H. Robinson Worldwide, Inc. SEC Filing
Rhea-AI Filing Summary
C.H. Robinson Worldwide, Inc. (CHRW) filed a Form 144 notifying a proposed sale of 5,713 common shares with an aggregate market value of $664,096.36. The notice identifies Fidelity Brokerage Services LLC as the broker and lists the approximate date of sale as 08/11/2025 on NASDAQ. The filing states total shares outstanding of 118,091,162.
The securities to be sold were acquired through employee stock purchase plan purchases on multiple dates (2019–2023) and restricted stock vesting in 2022 and 2024, with listed lots including 894 and 4,156 shares from vesting. The filing also reports a prior sale on 05/14/2025 of 5,700 shares by the Angela K Freeman Revocable Trust for $555,322.50.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Form 144 disclosing a planned sale of 5,713 CHRW shares; details show acquisition lots and a recent related sale.
The filing is a standard Rule 144 notice documenting a proposed sale through Fidelity Brokerage Services LLC of 5,713 common shares with an aggregate market value of $664,096.36, to occur approximately on 08/11/2025 on NASDAQ. It lists specific acquisition lots from ESPP purchases (2019–2023) and restricted stock vesting (02/15/2022 and 02/15/2024). The inclusion of a prior sale on 05/14/2025 (5,700 shares, $555,322.50) provides recent transaction context. For investors, this is a disclosure of insider-related selling activity rather than an operational disclosure.
TL;DR: Filing complies with disclosure rules and enumerates acquisition sources and a recent trust sale, indicating procedural transparency.
The Form 144 enumerates the provenance of shares proposed for sale—ESPP purchases and restricted stock vesting—providing clear traceability for securities subject to Rule 144. It names the executing broker and the exchange, and it includes a prior transaction by an affiliated trust dated 05/14/2025. The filing also carries the standard representation that the seller is not aware of undisclosed material adverse information. From a governance perspective, the document fulfills required public notification of intended insider-related sales.